subscribe
 

Drug development portfolio expands

AkzoNobel Specialty Chemicals expands offering of Kromasil products to support drug development



Mini freeze dryer mimics performance of larger dryers

The LyoCapsule freeze dryer's small chamber incorporates a cylindrical inner chamber, or ‘capsule,’ to hold the vials



Drug encapsulation

Telos droplet system is designed for high throughput and easy scale up



Analysis of erythropoietin (EPO) glycosylation

Ludger has developed accurate and reliable methods for analysis of EPO



Nucleation technology and the freeze drying process

SP Scientific has implemented ControLyo technology on their LyoStar3 freeze dryer systems



The importance of stability testing

Naomi Dunning-Foreman explains why stability testing is an essential step on the path to drug development



Streamlining cell culture workflow

From live cell observation and documentation to cell sampling and handling



Virtual screening software for cancer research

Blaze will be used to run virtual screening projects to translate research discoveries into new cancer drugs



Ethnobridging and the Asian Market

Pharmaceutical studies must take into account cultural differences, as well as regulations that require the use of clinical data from native populations, Stanford Jhee reports



Optimum heat uniformity for enhanced drying

Camille Flores reveals the latest in drying technology for use in the lab



Identifying potential cardiotoxicity

GE Healthcare launches Cytiva Plus cardiomyocytes for improved compound safety profiling



Novel strategy to molecular anti-cancer therapy tricks malignant cells

New drug prevents tumour growth by inhibiting the nucleotide sanitising enzyme MTH1



Using Lego-like DNA to create simple and low cost drug discovery and diagnostic tools

Scientists at the University of Southampton have helped to develop artificial membrane pores, using Lego-like DNA building blocks, which could provide a simple and low cost tool for drug discovery and diagnostic devices.



Novozymes Biopharma announces collaboration with Almac

Novozymes Biopharma is delighted to announce its new collaboration with Almac, to provide a combined service for drug development applications in the field of drug targeting and pharmacokinetic improvements.



Imaxio announces the first human clinical trial using its pro-immunogenic technology IMX313 in tuberculosis

IMX313, Imaxio’s antigen re-engineering technology, has been administrated for the first time in humans as part of a tuberculosis vaccine phase I clinical trial managed by the Jenner Institute at Oxford University



Novartis receives EU approval for Ilaris®

Novartis receives EU approval for Ilaris® in active Systemic Juvenile Idiopathic Arthritis, a serious form of childhood arthritis



Neutron studies of HIV inhibitors

Neutron studies of HIV inhibitors reveal new areas for improvement in drug design to enhance performance, combat resistance and reduce dosage.



Teaching old drugs new tricks

Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new way of identifying fresh market applications for drugs nearing the end of their product lifecycle.



Almac announces further expansion and new jobs

Craigavon-based pharmaceutical company Almac, has announced the commercial manufacturing expansion. Over the next three years up to 229 jobs will be created.



Training course in preparing stable lyophilized protein formulations

SP Scientific has announced a new hands-on training course entitled 'Rapid and Rational Development of Stable Lyophilized Protein Formulations'.



Pages

Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe